Ces Urol 2006, 10(1):59-63 | DOI: 10.48095/cccu2006013

The influence of indwelling stent on treatment results of ureteric stones in vivo

A. Petřík1, E. Alterová1, M. Fiala1, J. Novák1, F. Zá»ura2
1 Urologické oddělení Nemocnice České Budějovice a.s.,
2 Urologická klinika Univerzity Palackého Olomouc

Concrement fragmentation in the ureter using ESWL is influenced by the type and properties of the device used, particularly including the Shockwave type and the way of targeting the concrement, the total energy used during therapy, and the Shockwave frequency. Of major importance is also the strucuture of the concrement as well as the presence of a stent. In a retrospective study we evaluated the influence of stent placement in treating ureterolithiasis using extracorporeal lithotripsy. In cases with placement of double pigtail stent, a higher retreatment rate of 1.92 was found as compared to that of 1.56 with in situ therapy (p = < 0.0001) suggesting a negative influence of the double pigtail on ureterolithiasis fragmentation. When evaluating therapy effectiveness using Rassweiler's Efficacy Quotient, better outcomes were obtained for the in situ therapy group (47.76) as compared to the therapy with double pigtail placement (26.39) (p = < 0.0001) suggesting a negative influence of the stent on the outcomes of therapy for ureterolithiasis using ESWL. This fact confirms the previous results of an in vitro experiment. The outcome for clinical practice is to indicate ESWL primarily without stent placement.

Keywords: ESWL, ureteral stone, fragmentation, J-J stentESWL, ureteral stone, fragmentation, J-J stent

Published: January 1, 2006 


References

  1. Chaussy C, Schmiedt E, Jocham D, Brendel W, Forssmann B, Walther, V. First clinical experience with extracorporeally induced destruction of kidney stones by shock waves. J Urol 1982; 127: 417-420. Go to original source... Go to PubMed...
  2. Chaussy C, Fuchs G. Current State and Future Developments of Non-invasive Treatment of Human Urinary Stones with Extracorporeal Shock Wave Lithotripsy. J Urol 1989; 141: 782-789. Go to original source... Go to PubMed...
  3. Chaussy C, Schmiedt E. Shock wave treatment for stones in the upper urinary tract. Urol Clin North Am 1983; 10: 743-50. Go to original source...
  4. Segura, JW, Preminger GM, Assimos DG, Dretler SP, Kahn RI, Lingeman JE, Macaluso JN Jr. Ureteral stones clinical guidelines panel summary Report on the management of ureteral calculi. J Urol 1997; 158: 1915-21. Go to original source... Go to PubMed...
  5. Cass AS. Do upper ureteral stones need to be manipulated (push back) into the kidney before extracorporeal shock wave lithotripsy? J Urol 1992; 147: 349-51. Go to original source... Go to PubMed...
  6. Thompson AC, Shamsuddin AB, Mishriki SF, Crock P, Ramsay JWA. In situ ESWL for Ureteric Stones: the Adverse Effect of JJ Stenting. Br J Urol 1996; 77 (Suppl. 1); 5.
  7. Petřík A, Zá»ura F, Beneą J. Vliv stentingu na dezintegraci ureterolitiázy in vitro. Česká urologie 2004; 3: 45-48.
  8. Harada M, Inaba Y, Okamoto M. Treatment of ureteral stones by extracorporeal shock wave lithotripsy: with ureteral catheter or in situ? J Endourol 1994; 8: 9-11. Go to original source... Go to PubMed...
  9. Dawson C, Whitfield HN. The long-term results of treatment of urinary stones. Br J Urol 1994; 74 (4): 397-404. Go to original source... Go to PubMed...
  10. Whitfield HN. The management of ureteric stones. Part II: therapy. BJU Int 1999; 84 (8): 916-921. Go to original source... Go to PubMed...
  11. Ryan PC, Lennon GM, McLean PA, Fitzpatrick JM. The effects of acute and chronic JJ stent placement on upper urinary tract motility and calculus transit. Br J Urol 1994; 74: 434-9. Go to original source... Go to PubMed...
  12. Pace KT, Weir MJ, Tariq N, Honey RJ. Low success rate of repeat shock wave lithotripsy for ureteral stones after failed initial treatment. J Urol 2000; 164: 1905-7. Go to original source... Go to PubMed...
  13. Tolley DA. Consensus on lithotriptor terminology. World J Urol 1993; 11: 37-42. Go to original source... Go to PubMed...
  14. Tolley DA,Wallace DM, Tiptaft RC. First UK consensus conference on lithotriptor terminology - 1989. Br J Urol 1991; 67 (1): 9-12.
  15. Denstedt JD, Clayman RV, Preminger GM. Efficacy quotient as a means of comparing lithotripters. J Endourol 1990; (3): 100.
  16. Rassweiler J, Köhrmann K, Jünemann KP, Alken P. Use of electromagnetic technology. In: Smith AD. Controversie in endourology, WB Saunders Co 1995: 95-106.
  17. Thuroff S, Chaussy C. First clinical experience and in situ treatment of ureteric stones using Lithostar Multiline lithotripter. J Endourol 1995; (9): 367-70. Go to original source... Go to PubMed...
  18. Tailly GG. In situ SWL of ureteral stones: comparison between an electrohydraulic and an electromagnetic shockwave source. J Endourol 2002; (16): 209-14. Go to original source... Go to PubMed...
  19. Zhou Y, Cocks FH, Preminger GM, Zhong P. The effect of treatment strategy on stone comminution efficiency in shock wave lithotripsy. J Urol 2004; 172: 349-54. Go to original source... Go to PubMed...
  20. Paterson RF, Lifshitz DA, Lingeman JE, Evan AP, Connors BA, Fineberg NS, Williams JC, McAteer JA. Stone fragmentation during shock wave lithotripsy is improved by slowing the shock wave rate: studies with a new animal model. J Urol 2002; 168: 2211-5. Go to original source... Go to PubMed...
  21. Williams JC, Saw KC, Paterson RF, Hatt EK, McAteer JA, Lingeman JE. Variability of renal stone fragility in shock wave lithotripsy. Urology 2003; 61: 1092-6. Go to original source... Go to PubMed...
  22. Cass AS. Ureteral stenting with extracorporeal shock-wave lithotripsy. Urology 1992; 39: 446-8. Go to original source... Go to PubMed...
  23. Mobley TB, Myers DA, Jenkins JM, Grine WB, Jordan WR. Effects of stents on lithotripsy of ureteral calculi: treatment results with 18, 825 calculi using the Lithostar lithotriptor. J Urol 1994; 152: 53-6. Go to original source... Go to PubMed...





Web časopisu Česká urologie je určen pouze pro lékaře a odborníky
z oblasti medicíny nebo farmacie.



Beru na vědomí, ľe informace zveřejněné na těchto stránkách
nejsou určeny pro laickou veřejnost.



Odejít Vstoupit